Skip to content
  • Members
  • Action plan
  • Protocols
  • Activities
  • Submit new activity
  • Partners
  • Join
  • Members
  • Action plan
  • Protocols
  • Activities
  • Submit new activity
  • Partners
  • Join

admin

Lipidomic studies in serum COVID-19 patients

  • March 25, 2021March 26, 2021

Characterisation of protease activity during SARS-CoV-2 infection identifies novel viral cleavage sites and cellular targets for drug repurposing

  • March 25, 2021March 25, 2021

SAFE Coating – anti viral coating for wide spread use

  • March 25, 2021March 25, 2021

Identification, Mapping and Relative Quantitation of SARS-CoV-2 Spike Glycopeptides by Mass-Retention Time Fingerprinting

  • March 25, 2021March 25, 2021

Kynurenic acid underlies sex-specific immune responses to COVID-19

  • March 23, 2021March 25, 2021

Data, reagents, assays and merits of proteomics for SARS-CoV-2 research and testing

  • July 8, 2020March 25, 2021

Bioinformatics approaches for determining mass spectral signatures associated with COVID prognosis.

  • May 20, 2020March 25, 2021

LC-MS based proteomics for the elucidation of molecular processes involved in CoV2-host-interactions

  • May 20, 2020March 25, 2021

Université Laval, Québec city, Canada

  • May 20, 2020March 25, 2021

Metabolomics and Lipidomics Protocol

  • May 13, 2020May 13, 2020

COVID-19-MSC Metabolomics and Lipidomics Protocol This protocol covers the process from blood collection to dried sample for storage, and includes indicative protocols for subsequent LC-MS/MS… Read More »Metabolomics and Lipidomics Protocol

Covid19-MSC